Under what conditions can home use drugs become eligible?

Home use drugs can become eligible under the conditions of being designated as self-administration drugs. This refers to medications that patients can take independently outside of a healthcare setting. The eligibility hinges on the understanding that these drugs are meant for home use and are safely administered by the patients themselves without healthcare professional oversight during administration.

Self-administration plays a critical role in expanding access to essential medications, particularly for patients with chronic conditions who need continuous treatment without frequent hospital visits. The 340B Program recognizes this need and allows certain self-administered drugs to be included in the program, thereby enabling eligible healthcare entities to provide these medications at reduced prices.

Other options, while they highlight various aspects of drug prescription and dispensing, do not align with the specific criteria set out for home use eligibility under the 340B Program. For instance, simply being prescribed by a physician does not automatically qualify a drug for home use; the emphasis is on the patient's ability to self-administer the medication safely. Similarly, dispensing by a hospital pharmacy does not correlate directly with home use designation, and prior authorization from HRSA is not a standard condition for general eligibility of home use drugs within the framework of the program.